CNN State of the Union with Jake Tapper and Dana Bash August 15, 2021 16:13:00
Asking for what we want. and need. and we need more time. so, we want kisqali. living longer is possible and proven with kisqali when taken with fulvestrant or a nonsteroidal aromatase inhibitor in hr+, her2- metastatic breast cancer. kisqali is approved for both pre- and postmenopausal women, and has extended lives in multiple clinical trials. kisqali is a pill thats significantly more effective at delaying disease progression versus a nonsteroidal aromatase inhibitor or fulvestrant alone. kisq...
Breast Cancer Fulvestrant Ora Nonsteroidal Aromatase Inhibitor Aromatase Inhibitor Disease Progression Versus Liver Problems Chest Pain
Source: archive.org